ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Hip Osteoarthritis Pain Drug - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-32B6825
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Hip Osteoarthritis Pain Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Hip Osteoarthritis Pain Drug - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-32B6825
Report
November 2023
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Johnson and Johnson
GlaxoSmithKline PLC
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan NV
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma

Hip Osteoarthritis Pain Drug - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Hip Osteoarthritis Pain Drug - Market

Hip Osteoarthritis Pain Drug - Market

Hip Osteoarthritis Pain Drug is to relieve pain, and cannot slow the progress of osteoarthritis.
The global Hip Osteoarthritis Pain Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hip Osteoarthritis Pain Drug in various end use industries. The expanding demands from the Medical Care and Personal Care, are propelling Hip Osteoarthritis Pain Drug market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hip Osteoarthritis Pain Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Hip Osteoarthritis Pain Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hip Osteoarthritis Pain Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hip Osteoarthritis Pain Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hip Osteoarthritis Pain Drug covered in this report include Pfizer, Johnson and Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma and Abbott, etc.
The global Hip Osteoarthritis Pain Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Johnson and Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma

Scope of Hip Osteoarthritis Pain Drug - Market Report

Report Metric Details
Report Name Hip Osteoarthritis Pain Drug - Market
CAGR 5%
Global Hip Osteoarthritis Pain Drug market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hip Osteoarthritis Pain Drug market, Segment by Type:
  • Oral
  • Injection
  • External
Global Hip Osteoarthritis Pain Drug market, by Application
  • Medical Care
  • Personal Care
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Hip Osteoarthritis Pain Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Hip Osteoarthritis Pain Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the Hip Osteoarthritis Pain Drug - Market report?

Ans: The Applications covered in the Hip Osteoarthritis Pain Drug - Market report are Medical Care, Personal Care

What are the Type segmentation covered in the Hip Osteoarthritis Pain Drug - Market report?

Ans: The Types covered in the Hip Osteoarthritis Pain Drug - Market report are Oral, Injection, External

1 Hip Osteoarthritis Pain Drug Market Overview
1.1 Hip Osteoarthritis Pain Drug Product Overview
1.2 Hip Osteoarthritis Pain Drug Market Segment by Type
1.2.1 Oral
1.2.2 Injection
1.2.3 External
1.3 Global Hip Osteoarthritis Pain Drug Market Size by Type
1.3.1 Global Hip Osteoarthritis Pain Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Hip Osteoarthritis Pain Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hip Osteoarthritis Pain Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hip Osteoarthritis Pain Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hip Osteoarthritis Pain Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hip Osteoarthritis Pain Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hip Osteoarthritis Pain Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hip Osteoarthritis Pain Drug Sales Breakdown by Type (2018-2023)
2 Global Hip Osteoarthritis Pain Drug Market Competition by Company
2.1 Global Top Players by Hip Osteoarthritis Pain Drug Sales (2018-2023)
2.2 Global Top Players by Hip Osteoarthritis Pain Drug Revenue (2018-2023)
2.3 Global Top Players by Hip Osteoarthritis Pain Drug Price (2018-2023)
2.4 Global Top Manufacturers Hip Osteoarthritis Pain Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hip Osteoarthritis Pain Drug Market Competitive Situation and Trends
2.5.1 Hip Osteoarthritis Pain Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hip Osteoarthritis Pain Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hip Osteoarthritis Pain Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Hip Osteoarthritis Pain Drug Market
2.8 Key Manufacturers Hip Osteoarthritis Pain Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hip Osteoarthritis Pain Drug Status and Outlook by Region
3.1 Global Hip Osteoarthritis Pain Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hip Osteoarthritis Pain Drug Historic Market Size by Region
3.2.1 Global Hip Osteoarthritis Pain Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Hip Osteoarthritis Pain Drug Sales in Value by Region (2018-2023)
3.2.3 Global Hip Osteoarthritis Pain Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hip Osteoarthritis Pain Drug Forecasted Market Size by Region
3.3.1 Global Hip Osteoarthritis Pain Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Hip Osteoarthritis Pain Drug Sales in Value by Region (2024-2029)
3.3.3 Global Hip Osteoarthritis Pain Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hip Osteoarthritis Pain Drug by Application
4.1 Hip Osteoarthritis Pain Drug Market Segment by Application
4.1.1 Medical Care
4.1.2 Personal Care
4.2 Global Hip Osteoarthritis Pain Drug Market Size by Application
4.2.1 Global Hip Osteoarthritis Pain Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Hip Osteoarthritis Pain Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hip Osteoarthritis Pain Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hip Osteoarthritis Pain Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hip Osteoarthritis Pain Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hip Osteoarthritis Pain Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hip Osteoarthritis Pain Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hip Osteoarthritis Pain Drug Sales Breakdown by Application (2018-2023)
5 North America Hip Osteoarthritis Pain Drug by Country
5.1 North America Hip Osteoarthritis Pain Drug Historic Market Size by Country
5.1.1 North America Hip Osteoarthritis Pain Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hip Osteoarthritis Pain Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Hip Osteoarthritis Pain Drug Sales in Value by Country (2018-2023)
5.2 North America Hip Osteoarthritis Pain Drug Forecasted Market Size by Country
5.2.1 North America Hip Osteoarthritis Pain Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Hip Osteoarthritis Pain Drug Sales in Value by Country (2024-2029)
6 Europe Hip Osteoarthritis Pain Drug by Country
6.1 Europe Hip Osteoarthritis Pain Drug Historic Market Size by Country
6.1.1 Europe Hip Osteoarthritis Pain Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hip Osteoarthritis Pain Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Hip Osteoarthritis Pain Drug Sales in Value by Country (2018-2023)
6.2 Europe Hip Osteoarthritis Pain Drug Forecasted Market Size by Country
6.2.1 Europe Hip Osteoarthritis Pain Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Hip Osteoarthritis Pain Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Hip Osteoarthritis Pain Drug by Region
7.1 Asia-Pacific Hip Osteoarthritis Pain Drug Historic Market Size by Region
7.1.1 Asia-Pacific Hip Osteoarthritis Pain Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hip Osteoarthritis Pain Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hip Osteoarthritis Pain Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hip Osteoarthritis Pain Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Hip Osteoarthritis Pain Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hip Osteoarthritis Pain Drug Sales in Value by Region (2024-2029)
8 Latin America Hip Osteoarthritis Pain Drug by Country
8.1 Latin America Hip Osteoarthritis Pain Drug Historic Market Size by Country
8.1.1 Latin America Hip Osteoarthritis Pain Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hip Osteoarthritis Pain Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hip Osteoarthritis Pain Drug Sales in Value by Country (2018-2023)
8.2 Latin America Hip Osteoarthritis Pain Drug Forecasted Market Size by Country
8.2.1 Latin America Hip Osteoarthritis Pain Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hip Osteoarthritis Pain Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Hip Osteoarthritis Pain Drug by Country
9.1 Middle East and Africa Hip Osteoarthritis Pain Drug Historic Market Size by Country
9.1.1 Middle East and Africa Hip Osteoarthritis Pain Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hip Osteoarthritis Pain Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hip Osteoarthritis Pain Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hip Osteoarthritis Pain Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Hip Osteoarthritis Pain Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hip Osteoarthritis Pain Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Hip Osteoarthritis Pain Drug Products Offered
10.1.5 Pfizer Recent Development
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Company Information
10.2.2 Johnson and Johnson Introduction and Business Overview
10.2.3 Johnson and Johnson Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Johnson and Johnson Hip Osteoarthritis Pain Drug Products Offered
10.2.5 Johnson and Johnson Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline Hip Osteoarthritis Pain Drug Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Bayer
10.4.1 Bayer Company Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bayer Hip Osteoarthritis Pain Drug Products Offered
10.4.5 Bayer Recent Development
10.5 Eli Lilly
10.5.1 Eli Lilly Company Information
10.5.2 Eli Lilly Introduction and Business Overview
10.5.3 Eli Lilly Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Eli Lilly Hip Osteoarthritis Pain Drug Products Offered
10.5.5 Eli Lilly Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Hip Osteoarthritis Pain Drug Products Offered
10.6.5 Novartis Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sanofi Hip Osteoarthritis Pain Drug Products Offered
10.7.5 Sanofi Recent Development
10.8 Horizon Pharma
10.8.1 Horizon Pharma Company Information
10.8.2 Horizon Pharma Introduction and Business Overview
10.8.3 Horizon Pharma Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Horizon Pharma Hip Osteoarthritis Pain Drug Products Offered
10.8.5 Horizon Pharma Recent Development
10.9 Abbott
10.9.1 Abbott Company Information
10.9.2 Abbott Introduction and Business Overview
10.9.3 Abbott Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Abbott Hip Osteoarthritis Pain Drug Products Offered
10.9.5 Abbott Recent Development
10.10 Mylan
10.10.1 Mylan Company Information
10.10.2 Mylan Introduction and Business Overview
10.10.3 Mylan Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Mylan Hip Osteoarthritis Pain Drug Products Offered
10.10.5 Mylan Recent Development
10.11 Daiichi Sankyo
10.11.1 Daiichi Sankyo Company Information
10.11.2 Daiichi Sankyo Introduction and Business Overview
10.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Daiichi Sankyo Hip Osteoarthritis Pain Drug Products Offered
10.11.5 Daiichi Sankyo Recent Development
10.12 TEVA
10.12.1 TEVA Company Information
10.12.2 TEVA Introduction and Business Overview
10.12.3 TEVA Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 TEVA Hip Osteoarthritis Pain Drug Products Offered
10.12.5 TEVA Recent Development
10.13 Almatica Pharma
10.13.1 Almatica Pharma Company Information
10.13.2 Almatica Pharma Introduction and Business Overview
10.13.3 Almatica Pharma Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Almatica Pharma Hip Osteoarthritis Pain Drug Products Offered
10.13.5 Almatica Pharma Recent Development
10.14 Astellas Pharma
10.14.1 Astellas Pharma Company Information
10.14.2 Astellas Pharma Introduction and Business Overview
10.14.3 Astellas Pharma Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Astellas Pharma Hip Osteoarthritis Pain Drug Products Offered
10.14.5 Astellas Pharma Recent Development
10.15 Tide Pharmaceutical
10.15.1 Tide Pharmaceutical Company Information
10.15.2 Tide Pharmaceutical Introduction and Business Overview
10.15.3 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Products Offered
10.15.5 Tide Pharmaceutical Recent Development
10.16 Iroko Pharmaceuticals
10.16.1 Iroko Pharmaceuticals Company Information
10.16.2 Iroko Pharmaceuticals Introduction and Business Overview
10.16.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Products Offered
10.16.5 Iroko Pharmaceuticals Recent Development
10.17 Hengrui Pharmaceutical
10.17.1 Hengrui Pharmaceutical Company Information
10.17.2 Hengrui Pharmaceutical Introduction and Business Overview
10.17.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Products Offered
10.17.5 Hengrui Pharmaceutical Recent Development
10.18 Abiogen Pharma
10.18.1 Abiogen Pharma Company Information
10.18.2 Abiogen Pharma Introduction and Business Overview
10.18.3 Abiogen Pharma Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Abiogen Pharma Hip Osteoarthritis Pain Drug Products Offered
10.18.5 Abiogen Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hip Osteoarthritis Pain Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hip Osteoarthritis Pain Drug Industrial Chain Analysis
11.4 Hip Osteoarthritis Pain Drug Market Dynamics
11.4.1 Hip Osteoarthritis Pain Drug Industry Trends
11.4.2 Hip Osteoarthritis Pain Drug Market Drivers
11.4.3 Hip Osteoarthritis Pain Drug Market Challenges
11.4.4 Hip Osteoarthritis Pain Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hip Osteoarthritis Pain Drug Distributors
12.3 Hip Osteoarthritis Pain Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Johnson and Johnson
GlaxoSmithKline PLC
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan NV
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
List of Tables
    Table 1. Major Company of Oral
    Table 2. Major Company of Injection
    Table 3. Major Company of External
    Table 4. Global Hip Osteoarthritis Pain Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 5. Global Hip Osteoarthritis Pain Drug Sales by Type (2018-2023) & (K Units)
    Table 6. Global Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type (2018-2023)
    Table 7. Global Hip Osteoarthritis Pain Drug Sales by Type (2018-2023) & (US& Million)
    Table 8. Global Hip Osteoarthritis Pain Drug Market Share in Value by Type (2018-2023)
    Table 9. Global Hip Osteoarthritis Pain Drug Price by Type (2018-2023) & (USD/Unit)
    Table 10. Global Hip Osteoarthritis Pain Drug Sales by Type (2024-2029) & (K Units)
    Table 11. Global Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type (2024-2029)
    Table 12. Global Hip Osteoarthritis Pain Drug Sales by Type (2024-2029) & (US$ Million)
    Table 13. Global Hip Osteoarthritis Pain Drug Sales Market Share in Value by Type (2024-2029)
    Table 14. Global Hip Osteoarthritis Pain Drug Price by Type (2024-2029) & (USD/Unit)
    Table 15. North America Hip Osteoarthritis Pain Drug Sales by Type (2018-2023) & (K Units)
    Table 16. North America Hip Osteoarthritis Pain Drug Sales by Type (2018-2023) & (US$ Million)
    Table 17. Europe Hip Osteoarthritis Pain Drug Sales (K Units) by Type (2018-2023)
    Table 18. Europe Hip Osteoarthritis Pain Drug Sales by Type (2018-2023) & (US$ Million)
    Table 19. Asia-Pacific Hip Osteoarthritis Pain Drug Sales (K Units) by Type (2018-2023)
    Table 20. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Type (2018-2023) & (US$ Million)
    Table 21. Latin America Hip Osteoarthritis Pain Drug Sales (K Units) by Type (2018-2023)
    Table 22. Latin America Hip Osteoarthritis Pain Drug Sales by Type (2018-2023) & (US$ Million)
    Table 23. Middle East and Africa Hip Osteoarthritis Pain Drug Sales (K Units) by Type (2018-2023)
    Table 24. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Type (2018-2023) & (US$ Million)
    Table 25. Global Hip Osteoarthritis Pain Drug Sales by Company (2018-2023) & (K Units)
    Table 26. Global Hip Osteoarthritis Pain Drug Sales Share by Company (2018-2023)
    Table 27. Global Hip Osteoarthritis Pain Drug Revenue by Company (2018-2023) & (US$ Million)
    Table 28. Global Hip Osteoarthritis Pain Drug Revenue Share by Company (2018-2023)
    Table 29. Global Market Hip Osteoarthritis Pain Drug Price by Company (2018-2023) & (USD/Unit)
    Table 30. Global Hip Osteoarthritis Pain Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 31. Global Hip Osteoarthritis Pain Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hip Osteoarthritis Pain Drug as of 2022)
    Table 33. Date of Key Manufacturers Enter into Hip Osteoarthritis Pain Drug Market
    Table 34. Key Manufacturers Hip Osteoarthritis Pain Drug Product Type
    Table 35. Mergers & Acquisitions, Expansion Plans
    Table 36. Global Hip Osteoarthritis Pain Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Global Hip Osteoarthritis Pain Drug Sales by Region (2018-2023) & (K Units)
    Table 38. Global Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Region (2018-2023)
    Table 39. Global Hip Osteoarthritis Pain Drug Sales by Region (2018-2023) & (US$ Million)
    Table 40. Global Hip Osteoarthritis Pain Drug Sales Market Share in Value by Region (2018-2023)
    Table 41. Global Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 42. Global Hip Osteoarthritis Pain Drug Sales by Region (2024-2029) & (K Units)
    Table 43. Global Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Region (2024-2029)
    Table 44. Global Hip Osteoarthritis Pain Drug Sales by Region (2024-2029) & (US$ Million)
    Table 45. Global Hip Osteoarthritis Pain Drug Sales Market Share in Value by Region (2024-2029)
    Table 46. Global Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
    Table 47. Global Hip Osteoarthritis Pain Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 48. Global Hip Osteoarthritis Pain Drug Sales by Application (2018-2023) & (K Units)
    Table 49. Global Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Application (2018-2023)
    Table 50. Global Hip Osteoarthritis Pain Drug Sales by Application (2018-2023) & (US$ Million)
    Table 51. Global Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application (2018-2023)
    Table 52. Global Hip Osteoarthritis Pain Drug Price by Application (2018-2023) & (USD/Unit)
    Table 53. Global Hip Osteoarthritis Pain Drug Sales by Application (2024-2029) & (K Units)
    Table 54. Global Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Application (2024-2029)
    Table 55. Global Hip Osteoarthritis Pain Drug Sales by Application (2024-2029) & (US$ Million)
    Table 56. Global Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application (2024-2029)
    Table 57. Global Hip Osteoarthritis Pain Drug Price by Application (2024-2029) & (USD/Unit)
    Table 58. North America Hip Osteoarthritis Pain Drug Sales by Application (2018-2023) (K Units)
    Table 59. North America Hip Osteoarthritis Pain Drug Sales by Application (2018-2023) & (US$ Million)
    Table 60. Europe Hip Osteoarthritis Pain Drug Sales by Application (2018-2023) (K Units)
    Table 61. Europe Hip Osteoarthritis Pain Drug Sales by Application (2018-2023) & (US$ Million)
    Table 62. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Application (2018-2023) (K Units)
    Table 63. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Application (2018-2023) & (US$ Million)
    Table 64. Latin America Hip Osteoarthritis Pain Drug Sales by Application (2018-2023) (K Units)
    Table 65. Latin America Hip Osteoarthritis Pain Drug Sales by Application (2018-2023) & (US$ Million)
    Table 66. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Application (2018-2023) (K Units)
    Table 67. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Application (2018-2023) & (US$ Million)
    Table 68. North America Hip Osteoarthritis Pain Drug Sales by Country (2018-2023) & (K Units)
    Table 69. North America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2018-2023)
    Table 70. North America Hip Osteoarthritis Pain Drug Sales by Country (2018-2023) & (US$ Million)
    Table 71. North America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2018-2023)
    Table 72. North America Hip Osteoarthritis Pain Drug Sales by Country (2024-2029) & (K Units)
    Table 73. North America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2024-2029)
    Table 74. North America Hip Osteoarthritis Pain Drug Sales by Country (2024-2029) & (US$ Million)
    Table 75. North America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2024-2029)
    Table 76. Europe Hip Osteoarthritis Pain Drug Sales by Country (2018-2023) & (K Units)
    Table 77. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2018-2023)
    Table 78. Europe Hip Osteoarthritis Pain Drug Sales by Country (2018-2023) & (US$ Million)
    Table 79. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2018-2023)
    Table 80. Europe Hip Osteoarthritis Pain Drug Sales by Country (2024-2029) & (K Units)
    Table 81. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2024-2029)
    Table 82. Europe Hip Osteoarthritis Pain Drug Sales by Country (2024-2029) & (US$ Million)
    Table 83. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2024-2029)
    Table 84. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Region (2018-2023) & (K Units)
    Table 85. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Region (2018-2023)
    Table 86. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Region (2018-2023) & (US$ Million)
    Table 87. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Value by Region (2018-2023)
    Table 88. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Region (2024-2029) & (K Units)
    Table 89. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Region (2024-2029)
    Table 90. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Value by Region (2024-2029)
    Table 92. Latin America Hip Osteoarthritis Pain Drug Sales by Country (2018-2023) & (K Units)
    Table 93. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2018-2023)
    Table 94. Latin America Hip Osteoarthritis Pain Drug Sales by Country (2018-2023) & (US$ Million)
    Table 95. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2018-2023)
    Table 96. Latin America Hip Osteoarthritis Pain Drug Sales by Country (2024-2029) & (K Units)
    Table 97. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2024-2029)
    Table 98. Latin America Hip Osteoarthritis Pain Drug Sales by Country (2024-2029) & (US$ Million)
    Table 99. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2024-2029)
    Table 100. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country (2018-2023) & (K Units)
    Table 101. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2018-2023)
    Table 102. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country (2018-2023) & (US$ Million)
    Table 103. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2018-2023)
    Table 104. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country (2024-2029) & (K Units)
    Table 105. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Country (2024-2029)
    Table 106. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country (2024-2029) & (US$ Million)
    Table 107. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Value by Country (2024-2029)
    Table 108. Pfizer Company Information
    Table 109. Pfizer Introduction and Business Overview
    Table 110. Pfizer Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 111. Pfizer Hip Osteoarthritis Pain Drug Product
    Table 112. Pfizer Recent Development
    Table 113. Johnson and Johnson Company Information
    Table 114. Johnson and Johnson Introduction and Business Overview
    Table 115. Johnson and Johnson Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 116. Johnson and Johnson Hip Osteoarthritis Pain Drug Product
    Table 117. Johnson and Johnson Recent Development
    Table 118. GlaxoSmithKline Company Information
    Table 119. GlaxoSmithKline Introduction and Business Overview
    Table 120. GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 121. GlaxoSmithKline Hip Osteoarthritis Pain Drug Product
    Table 122. GlaxoSmithKline Recent Development
    Table 123. Bayer Company Information
    Table 124. Bayer Introduction and Business Overview
    Table 125. Bayer Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 126. Bayer Hip Osteoarthritis Pain Drug Product
    Table 127. Bayer Recent Development
    Table 128. Eli Lilly Company Information
    Table 129. Eli Lilly Introduction and Business Overview
    Table 130. Eli Lilly Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 131. Eli Lilly Hip Osteoarthritis Pain Drug Product
    Table 132. Eli Lilly Recent Development
    Table 133. Novartis Company Information
    Table 134. Novartis Introduction and Business Overview
    Table 135. Novartis Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 136. Novartis Hip Osteoarthritis Pain Drug Product
    Table 137. Novartis Recent Development
    Table 138. Sanofi Company Information
    Table 139. Sanofi Introduction and Business Overview
    Table 140. Sanofi Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 141. Sanofi Hip Osteoarthritis Pain Drug Product
    Table 142. Sanofi Recent Development
    Table 143. Horizon Pharma Company Information
    Table 144. Horizon Pharma Introduction and Business Overview
    Table 145. Horizon Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 146. Horizon Pharma Hip Osteoarthritis Pain Drug Product
    Table 147. Horizon Pharma Recent Development
    Table 148. Abbott Company Information
    Table 149. Abbott Introduction and Business Overview
    Table 150. Abbott Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 151. Abbott Hip Osteoarthritis Pain Drug Product
    Table 152. Abbott Recent Development
    Table 153. Mylan Company Information
    Table 154. Mylan Introduction and Business Overview
    Table 155. Mylan Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 156. Mylan Hip Osteoarthritis Pain Drug Product
    Table 157. Mylan Recent Development
    Table 158. Daiichi Sankyo Company Information
    Table 159. Daiichi Sankyo Introduction and Business Overview
    Table 160. Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 161. Daiichi Sankyo Hip Osteoarthritis Pain Drug Product
    Table 162. Daiichi Sankyo Recent Development
    Table 163. TEVA Company Information
    Table 164. TEVA Introduction and Business Overview
    Table 165. TEVA Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 166. TEVA Hip Osteoarthritis Pain Drug Product
    Table 167. TEVA Recent Development
    Table 168. Almatica Pharma Company Information
    Table 169. Almatica Pharma Introduction and Business Overview
    Table 170. Almatica Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 171. Almatica Pharma Hip Osteoarthritis Pain Drug Product
    Table 172. Almatica Pharma Recent Development
    Table 173. Astellas Pharma Company Information
    Table 174. Astellas Pharma Introduction and Business Overview
    Table 175. Astellas Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 176. Astellas Pharma Hip Osteoarthritis Pain Drug Product
    Table 177. Astellas Pharma Recent Development
    Table 178. Tide Pharmaceutical Company Information
    Table 179. Tide Pharmaceutical Introduction and Business Overview
    Table 180. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 181. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product
    Table 182. Tide Pharmaceutical Recent Development
    Table 183. Iroko Pharmaceuticals Company Information
    Table 184. Iroko Pharmaceuticals Introduction and Business Overview
    Table 185. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 186. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product
    Table 187. Iroko Pharmaceuticals Recent Development
    Table 188. Hengrui Pharmaceutical Company Information
    Table 189. Hengrui Pharmaceutical Introduction and Business Overview
    Table 190. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 191. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product
    Table 192. Hengrui Pharmaceutical Recent Development
    Table 193. Abiogen Pharma Company Information
    Table 194. Abiogen Pharma Introduction and Business Overview
    Table 195. Abiogen Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 196. Abiogen Pharma Hip Osteoarthritis Pain Drug Product
    Table 197. Abiogen Pharma Recent Development
    Table 198. Key Raw Materials Lists
    Table 199. Raw Materials Key Suppliers Lists
    Table 200. Hip Osteoarthritis Pain Drug Market Trends
    Table 201. Hip Osteoarthritis Pain Drug Market Drivers
    Table 202. Hip Osteoarthritis Pain Drug Market Challenges
    Table 203. Hip Osteoarthritis Pain Drug Market Restraints
    Table 204. Hip Osteoarthritis Pain Drug Distributors List
    Table 205. Hip Osteoarthritis Pain Drug Downstream Customers
    Table 206. Research Programs/Design for This Report
    Table 207. Key Data Information from Secondary Sources
    Table 208. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hip Osteoarthritis Pain Drug Product Picture
    Figure 2. Global Hip Osteoarthritis Pain Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Hip Osteoarthritis Pain Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Hip Osteoarthritis Pain Drug Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of Oral
    Figure 6. Global Oral Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Injection
    Figure 8. Global Injection Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Product Picture of External
    Figure 10. Global External Sales YoY Growth (2018-2029) & (K Units)
    Figure 11. Global Hip Osteoarthritis Pain Drug Sales by Type (2018-2029) & (US$ Million)
    Figure 12. Global Hip Osteoarthritis Pain Drug Sales Market Share by Type in 2022 & 2029
    Figure 13. North America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type in 2022
    Figure 14. North America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Type in 2022
    Figure 15. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type in 2022
    Figure 16. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Value by Type in 2022
    Figure 17. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type in 2022
    Figure 18. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Value by Type in 2022
    Figure 19. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type in 2022
    Figure 20. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Type in 2022
    Figure 21. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Type in 2022
    Figure 22. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Value by Type in 2022
    Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Hip Osteoarthritis Pain Drug Sales in 2022
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Hip Osteoarthritis Pain Drug Revenue in 2022
    Figure 25. Hip Osteoarthritis Pain Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 26. Product Picture of Medical Care
    Figure 27. Global Medical Care Sales YoY Growth (2018-2029) & (K Units)
    Figure 28. Product Picture of Personal Care
    Figure 29. Global Personal Care Sales YoY Growth (2018-2029) & (K Units)
    Figure 30. Global Hip Osteoarthritis Pain Drug Sales by Application (2018-2029) & (US$ Million)
    Figure 31. Global Hip Osteoarthritis Pain Drug Sales Market Share by Application in 2022 & 2029
    Figure 32. North America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Application in 2022
    Figure 33. North America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application in 2022
    Figure 34. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Application in 2022
    Figure 35. Europe Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application in 2022
    Figure 36. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Application in 2022
    Figure 37. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application in 2022
    Figure 38. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Volume by Application in 2022
    Figure 39. Latin America Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application in 2022
    Figure 40. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share in Value by Application in 2022
    Figure 41. Key Raw Materials Price
    Figure 42. Hip Osteoarthritis Pain Drug Manufacturing Cost Structure
    Figure 43. Hip Osteoarthritis Pain Drug Industrial Chain Analysis
    Figure 44. Channels of Distribution
    Figure 45. Distributors Profiles
    Figure 46. Bottom-up and Top-down Approaches for This Report
    Figure 47. Data Triangulation
    Figure 48. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34R905
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34L14446
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Oral OTC Analgesics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-16Y2908
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Dysthymia Clinical Trial Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2P6528
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions